Despite the market's robust growth, several challenges remain. The high cost of advanced stents and the procedures for their implantation can be a significant barrier for patients, particularly in developing regions. Additionally, stringent regulatory approval processes and the risk of complications, such as blood clots (thrombosis), require continuous innovation and rigorous clinical trials. These factors necessitate a balance between technological advancement and cost-effectiveness. https://www.marketresearchfutu....re.com/reports/coron
Like
Comment
Share
